BRPI0519022A2 - formaÇço insitu de implante para animais - Google Patents

formaÇço insitu de implante para animais

Info

Publication number
BRPI0519022A2
BRPI0519022A2 BRPI0519022-3A BRPI0519022A BRPI0519022A2 BR PI0519022 A2 BRPI0519022 A2 BR PI0519022A2 BR PI0519022 A BRPI0519022 A BR PI0519022A BR PI0519022 A2 BRPI0519022 A2 BR PI0519022A2
Authority
BR
Brazil
Prior art keywords
unsuitable
animal
training
animal implant
implant training
Prior art date
Application number
BRPI0519022-3A
Other languages
English (en)
Inventor
Caroline Sautter
Ute Isele
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0519022A2 publication Critical patent/BRPI0519022A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

FORMAÇçO INSITU DE IMPLANTE PARA ANIMAIS. A presente invenção refere-se a uma composição, compreendendo um polímero termoplástico, um agente de modificação de taxa e um agente biologicamente ativo, útil como um implante de liberação lenta do fármaco no corpo de um ser humano ou animal que pode ser administrada em forma liquida no corpo.
BRPI0519022-3A 2004-12-14 2005-12-13 formaÇço insitu de implante para animais BRPI0519022A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04029498 2004-12-14
PCT/EP2005/013377 WO2006063794A1 (en) 2004-12-14 2005-12-13 In-situ forming implant for animals

Publications (1)

Publication Number Publication Date
BRPI0519022A2 true BRPI0519022A2 (pt) 2008-12-23

Family

ID=34927750

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519022-3A BRPI0519022A2 (pt) 2004-12-14 2005-12-13 formaÇço insitu de implante para animais

Country Status (16)

Country Link
JP (1) JP5372378B2 (pt)
KR (1) KR101304160B1 (pt)
CN (1) CN101056617B (pt)
AR (1) AR052155A1 (pt)
AT (1) ATE389386T1 (pt)
AU (1) AU2005315823B2 (pt)
BR (1) BRPI0519022A2 (pt)
CA (1) CA2585779C (pt)
DE (1) DE602005005522T2 (pt)
ES (1) ES2301084T3 (pt)
MX (1) MX2007007099A (pt)
NZ (1) NZ554904A (pt)
RU (1) RU2394558C2 (pt)
TW (1) TWI369218B (pt)
WO (1) WO2006063794A1 (pt)
ZA (1) ZA200703506B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
EP2152315B1 (en) 2007-05-25 2016-01-06 Indivior UK Limited Sustained delivery formulations of risperidone compounds
CN101159064B (zh) 2007-11-29 2010-09-01 腾讯科技（深圳）有限公司 画像生成系统以及按照图像生成画像的方法
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
JP6543431B2 (ja) * 2013-10-10 2019-07-10 ユニバーシティー オブ ユタ リサーチ ファウンデーションＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｕｔａｈ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 眼内薬物送達デバイスおよび付随する方法
PL3609470T3 (pl) * 2017-04-13 2024-04-15 Ceva Santé Animale Implant do leczenia infekcji pasożytniczej
CN112336682B (zh) * 2020-09-28 2022-07-08 浙江大学 具有缓控释药物作用的可注射复合载体与组合物及制备方法
WO2024003291A1 (en) 2022-06-30 2024-01-04 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
ATE318580T1 (de) * 1996-12-20 2006-03-15 Alza Corp Gelzusammensetzungen und verfahren
WO1999042147A1 (en) * 1998-02-23 1999-08-26 Massachusetts Institute Of Technology Biodegradable shape memory polymers
KR100684055B1 (ko) * 1998-03-19 2007-02-16 머크 앤드 캄파니 인코포레이티드 생물활성 물질의 방출 조절용 액체 중합체성 조성물
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
JP4317606B2 (ja) * 1998-09-18 2009-08-19 サンスター株式会社 固体粒子形成用組成物
US7368126B2 (en) * 2002-11-06 2008-05-06 Guohua Chen Controlled release depot formulations
WO2004081196A2 (en) * 2003-03-11 2004-09-23 Qlt Usa Inc. Formulations for cell- schedule dependent anticancer agents

Also Published As

Publication number Publication date
KR101304160B1 (ko) 2013-09-04
CA2585779C (en) 2014-01-28
TW200635616A (en) 2006-10-16
DE602005005522D1 (de) 2008-04-30
KR20070092964A (ko) 2007-09-14
MX2007007099A (es) 2007-06-22
AU2005315823B2 (en) 2009-06-04
AU2005315823A1 (en) 2006-06-22
WO2006063794A1 (en) 2006-06-22
JP2008523131A (ja) 2008-07-03
TWI369218B (en) 2012-08-01
CA2585779A1 (en) 2006-06-22
AR052155A1 (es) 2007-03-07
CN101056617B (zh) 2012-07-11
RU2007126759A (ru) 2009-01-27
ZA200703506B (en) 2008-09-25
JP5372378B2 (ja) 2013-12-18
RU2394558C2 (ru) 2010-07-20
DE602005005522T2 (de) 2009-04-16
ATE389386T1 (de) 2008-04-15
ES2301084T3 (es) 2008-06-16
NZ554904A (en) 2009-11-27
CN101056617A (zh) 2007-10-17

Similar Documents

Publication Publication Date Title
AR063621A1 (es) Matriz polimerica insoluble en agua para la administracion de farmacos
MD20070267A (en) Gastroresistant pharmaceutical formulation containing rifaximin
DE602004007555D1 (de) Implantat zur okklusion eines körperkanals
ATE355065T1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
WO2010039641A3 (en) Long term drug delivery devices with polyurethane-based polymers and their manufacture
CL2003002277A1 (es) Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente.
ATE418325T1 (de) Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon- acetonid und hyaluronsäure
CY1111465T1 (el) Εμφυτευσιμη πολυμερικη ιατροτεχνολογικη συσκευη για κατακρατημενη αποδεσμευση του αγωνιστη δοπαμινης
WO2007089544A3 (en) Biodegradable non-ophthalmic implants and related methods
WO2010068281A3 (en) Contact lens drug delivery device
ATE432689T1 (de) Arzneimittelformulierungen mit verzögerter freisetzung mit einem trägerpeptid
BRPI0513243A (pt) composições oftálmicas e métodos para tratar condições oftálmicas
WO2007005716A3 (en) Methods of treatment and compositions for use thereof
EA201201569A1 (ru) Инъекционная композиция пролонгированного действия для введения антипсихотического препарата
DE602004030353D1 (de) Formulierungen enthaltend salicylate und deren verwendung zur behandlung von entzündlicher darmerkrankung
WO2014102613A3 (en) Device for disposal and neutralization of pharmaceutical agents
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
GT200400218A (es) Formulaciones de liberacion sostenida.
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
BRPI0415755A (pt) antagonistas do receptor b1 de bradiquinina
BRPI0512311A (pt) uso de meloxicam em medicina veterinária para o tratamento de doenças inflamatórias dolorosas
TN2012000194A1 (en) Antifungal mixture with fungal organism pythium oligandrum
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
EP1781277A4 (en) COMBINATION PREPARATION
BR0308710A (pt) conjugados poliméricos antimicrobianos

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: NOVARTIS AG (CH)

Free format text: A FIM DE ATENDER A TRANSFERENCIA REQUERIDA ATRAVES DA PETICAO NO 20150005919 DE 23/03/2015 , E NECESSARIO REAPRESENTAR O DOCUMENTO DE CESSAO COM AS ASSINATURAS NOTARIZADAS E A DEVIDA LEGALIZACAO CONSULAR.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B25B Requested transfer of rights rejected

Owner name: NOVARTIS AG (CH)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]